# Hospira, now a wholly owned subsidiary trials: 28 (2026)

ClinicalTrials.gov lists 28 trials with Hospira, now a wholly owned subsidiary of Pfizer as lead sponsor, 0 of them recruiting or not yet recruiting.

## The full list

Clinical trials led by Hospira, now a wholly owned subsidiary of Pfizer: 28 rows for $5, every trial on ClinicalTrials.gov. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/hospira-now-a-wholly-owned-subsidiary-of-pfizer

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 28
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 25 newest of 28, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| June 6, 2014 | NCT02158169 | Biosimilar Retacrit® in the Treatment of Chemotherapy-induced Anaemia in Oncology and Haematology | Hospira, now a wholly owned subsidiary of Pfizer | Observational | Completed | Chemotherapy-induced Anemia | 2,167 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02158169) |
| May 16, 2014 | NCT02140736 | Epoetin Alfa Biosimilar in the Management of Chemotherapy-Induced Symptomatic Anemia in Haematology and Oncology | Hospira, now a wholly owned subsidiary of Pfizer | Observational | Completed | Chemotherapy-induced Symptomatic Anemia, Solid Tumors, Malignant Hemopathies, Lymphomas, Myelomas | 2,333 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02140736) |
| March 18, 2013 | NCT01812538 | A Randomized, Single-Dose, Comparative, Positive and Placebo Controlled, Four-Way, Four Period, Cross-Over Study to Evaluate the Effect of... | Hospira, now a wholly owned subsidiary of Pfizer | Phase 1 | Completed | Ventricular Repolarization | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01812538) |
| June 26, 2012 | NCT01627990 | Nivestim™ in Treatment of Malignant Diseases | Hospira, now a wholly owned subsidiary of Pfizer | Observational | Completed | Solid Tumour, Malignant Haematological Tumour, Primary or Secondary Prophylactic Treatment | 386 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01627990) |
| June 22, 2012 | NCT01626547 | Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology | Hospira, now a wholly owned subsidiary of Pfizer | Observational | Completed | Chemotherapy-induced Symptomatic Anaemia, Solid Tumours, Malignant Lymphomas, Multiple Myeloma | 291 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01626547) |
| April 10, 2012 | NCT01574235 | Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents | Hospira, now a wholly owned subsidiary of Pfizer | Observational | Completed | Solid Tumors, Malignant Hemopathy, Chemotherapy-induced Febrile Neutropenia (FN) | 2,114 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01574235) |
| January 26, 2012 | NCT01519167 | Open-Label, Safety Study Evaluating the Use of Dexmedetomidine in Pediatric Subjects Undergoing Procedure-Type Sedation | Hospira, now a wholly owned subsidiary of Pfizer | Phase 4 | Completed | Ultrasound, CT Scans, MRIs | 91 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01519167) |
| January 12, 2012 | NCT01508455 | Open-Label, Safety, and Efficacy Study of Dexmedetomidine in Preterm Subjects Ages ≥28 Weeks to \<36 Weeks Gestational Age | Hospira, now a wholly owned subsidiary of Pfizer | Phase 2/3 | Completed | Anesthesia | 6 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01508455) |
| September 22, 2011 | NCT01438931 | Clinical Study to Investigate the Efficacy and the Safety of DA-9501 in Sedation During the Surgery or Medical Procedure Without Intubation | Hospira, now a wholly owned subsidiary of Pfizer | Phase 3 | Completed | Sedation | 162 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01438931) |
| June 23, 2011 | NCT01378988 | Phase II Pharmacokinetic and Pharmacodynamic Study of DEX in Subjects Aged 12 Months Through \<24 Months | Hospira, now a wholly owned subsidiary of Pfizer | Phase 2 | Completed | Sedation, Pain | 5 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01378988) |
| December 29, 2010 | NCT01268163 | The Pharmacokinetics and Safety Characteristics of Docetaxel in Patients With Cancer | Hospira, now a wholly owned subsidiary of Pfizer | Phase 1 | Completed | Cancer | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01268163) |
| July 27, 2010 | NCT01170078 | A Study Comparing the Effects of Epoetin Hospira and Epogen/Epoetin Alfa (Amgen) When Administered IV in Patients With Chronic Renal... | Hospira, now a wholly owned subsidiary of Pfizer | Phase 1 | Completed | Chronic Renal Failure | 107 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01170078) |
| July 26, 2010 | NCT01169571 | Study to Evaluate Hemodynamic Effect of Different Loading Doses of Precedex in Post-surgical Intensive Care Unit (ICU) Patients | Hospira, now a wholly owned subsidiary of Pfizer | Observational | Completed | Intensive Care Unit | 373 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01169571) |
| July 9, 2010 | NCT01159262 | Safety, Efficacy and Pharmacokinetic Study of Dexmedetomidine in Pediatrics Ages ≥28 Weeks to ≤44 Weeks Gestational Age | Hospira, now a wholly owned subsidiary of Pfizer | Phase 2/3 | Completed | Sedation | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01159262) |
| July 14, 2009 | NCT00938678 | Pharmacokinetic/Pharmacodynamic (PK/PD) Study Evaluating Pegfilgrastim Hospira Compared to Neulasta (Amgen) in Healthy Volunteers | Hospira, now a wholly owned subsidiary of Pfizer | Phase 1 | Completed | Healthy | 71 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00938678) |
| April 3, 2009 | NCT00875550 | Study Evaluating Safety and Efficacy of Dexmedetomidine (DEX) in Intubated and Mechanically Ventilated Pediatric Intensive Care Unit (PICU)... | Hospira, now a wholly owned subsidiary of Pfizer | Phase 3 | Completed | Sedation | 175 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00875550) |
| September 3, 2008 | NCT00745186 | Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy Volunteers | Hospira, now a wholly owned subsidiary of Pfizer | Phase 1 | Completed | Hypoglycemia | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00745186) |
| July 21, 2008 | NCT00719459 | Bioequivalency Study Comparing Hospira's Generic Iron Sucrose Injection to Venofer | Hospira, now a wholly owned subsidiary of Pfizer | Phase 1 | Completed | Healthy Volunteers | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00719459) |
| July 3, 2008 | NCT00709436 | Safety and Efficacy of Repeated Doses of PMI-150 (Intranasal Ketamine) in Acute Post-operative Pain Following Orthopedic Surgery | Hospira, now a wholly owned subsidiary of Pfizer | Phase 3 | Completed | Pain, Postoperative | 250 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00709436) |
| April 3, 2008 | NCT00652028 | Pharmacokinetics and Pharmacodynamics of Dexmedetomidine in Pediatrics Subjects | Hospira, now a wholly owned subsidiary of Pfizer | Phase 2 | Completed | Intubated and Mechanically Ventilated Pediatric Subjects | 69 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00652028) |
| September 10, 2007 | NCT00526760 | Long-term Clinical Study Evaluating the Safety and Efficacy of Dexmedetomidine in ICU Subjects | Hospira, now a wholly owned subsidiary of Pfizer | Phase 3 | Completed | Sedation | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00526760) |
| June 27, 2007 | NCT00492388 | Safety and Efficacy of PMI-150 (Intranasal Ketamine) for the Treatment of Breakthrough Pain in Cancer Patients | Hospira, now a wholly owned subsidiary of Pfizer | Phase 3 | Terminated | Pain, Cancer | 2 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00492388) |
| April 24, 2007 | NCT00464763 | A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Heart Surgery | Hospira, now a wholly owned subsidiary of Pfizer | Phase 3 | Withdrawn | Delirium | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00464763) |
| April 16, 2007 | NCT00460473 | A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery | Hospira, now a wholly owned subsidiary of Pfizer | Phase 3 | Terminated | Delirium | 52 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00460473) |
| November 14, 2006 | NCT00398827 | A Safety and Efficacy Study of Dexmedetomidine in Patients Requiring Sedation During Monitored Anesthesia Care (MAC) | Hospira, now a wholly owned subsidiary of Pfizer | Phase 3 | Completed | Anesthesia, Surgical Procedures, Elective | 326 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00398827) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 6 |
| Phase 2 | 2 |
| Phase 2/3 | 2 |
| Phase 3 | 9 |
| Phase 4 | 3 |
| Observational | 6 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 25 |
| Terminated | 2 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Pain | 3 |
| Delirium | 2 |
| Psychological Well-Being | 2 |
| Nervous System Diseases | 2 |
| Neoplasms | 2 |
| Lymphoma | 2 |
| Hypoglycemia | 1 |
| Neoplasms, Plasma Cell | 1 |
| Multiple Myeloma | 1 |
| Chemotherapy-Induced Febrile Neutropenia | 1 |
| Pain, Postoperative | 1 |
| Kidney Failure, Chronic | 1 |
| Hip Injuries | 1 |
| Disease | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Brazilian restaurants in the United States](https://specstream.ai/data/businesses/brazilian-restaurants/united-states)
- [B2B environmental companies in the United States](https://specstream.ai/data/businesses/b2b-environmental-companies/united-states)
- [Accounting firms in the United States](https://specstream.ai/data/businesses/accounting-firms/united-states)
- [Truck repair shops in the United States](https://specstream.ai/data/businesses/truck-repair-shops/united-states)
- [Sports bars in the United States](https://specstream.ai/data/businesses/sports-bars/united-states)
- [Remodeling contractors in the United States](https://specstream.ai/data/businesses/remodeling-contractors/united-states)
